Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.

Thousands of Oregon Hospital Patients May Have Been Exposed to Infectious Diseases

PORTLAND, Ore. (AP) — More than 2,400 patients at hospitals around Portland, Oregon, may have been exposed to infectious diseases such as hepatitis B and

July 13, 2024

Pfizer, BioNTech review next steps as Covid and flu combo vaccine delivers mixed data

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 17, 2024

With a promising new Keytruda contender, Summit prepares to spar with Merck

CHICAGO — Summit Therapeutics is prepared to take on the world’s best-selling drug. On Thursday, the biotech’s stock nearly tripled after reporting that its cancer

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.